Andrzej K Bednarek
Overview
Explore the profile of Andrzej K Bednarek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
739
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaluzinska-Kolat Z, Kolat D, Kosla K, Pluciennik E, Bednarek A
Front Neurosci
. 2023 Oct;
17:1260409.
PMID: 37781246
Introduction: Glioblastoma (GBM) is notorious for its clinical and molecular heterogeneity, contributing to therapeutic failure and a grim prognosis. is one of the tumor suppressor genes important in nervous tissue...
2.
Hamouz M, Hammouz R, Bajwa M, Alsayed A, Orzechowska M, Bednarek A
Int J Mol Sci
. 2023 Sep;
24(17).
PMID: 37686122
There is currently a dearth of information regarding lung cancer in never smokers (LCINS). Additionally, there is a difference in somatic mutations, tumour mutational burden, and chromosomal aberrations between smokers...
3.
Kolat D, Kaluzinska-Kolat Z, Kosla K, Orzechowska M, Pluciennik E, Bednarek A
Front Genet
. 2023 Jul;
14:1214968.
PMID: 37519886
The discovery of non-coding RNA (ncRNA) dates back to the pre-genomics era, but the progress in this field is still dynamic and leverages current post-genomics solutions. WWOX is a global...
4.
Kaluzinska-Kolat Z, Kolat D, Kosla K, Pluciennik E, Bednarek A
World J Stem Cells
. 2023 Jun;
15(5):302-322.
PMID: 37342224
Literature data on glioblastoma ongoingly underline the link between metabolism and cancer stemness, the latter is one responsible for potentiating the resistance to treatment, due to increased invasiveness. In recent...
5.
Olczak M, Orzechowska M, Bednarek A, Lipinski M
Int J Mol Sci
. 2023 May;
24(9).
PMID: 37176106
The molecular determinants of the heterogenic course of prostate cancer (PC) remain elusive. We aimed to determine the drivers predisposing to unfavorable PC outcomes anticipated by BCR events among patients...
6.
Kaluzinska-Kolat Z, Kosla K, Kolat D, Pluciennik E, Bednarek A
Biology (Basel)
. 2023 Mar;
12(3).
PMID: 36979157
Following the discovery of , research has moved in many directions, including the role of this putative tumor suppressor in the central nervous system and related diseases. The task of...
7.
Hammouz R, Orzechowska M, Anusewicz D, Bednarek A
Curr Oncol
. 2023 Feb;
30(2):1395-1415.
PMID: 36826068
Cellular metabolism is a tightly controlled process during which cell growth and survival are maintained. Lung cancer is a disease with clear sex differences, where female patients have better survival...
8.
Age- and Stage-Dependent Prostate Cancer Aggressiveness Associated with Differential Notch Signaling
Orzechowska M, Anusewicz D, Bednarek A
Int J Mol Sci
. 2023 Jan;
24(1).
PMID: 36613607
Prostate cancer (PC) remains a worldwide challenge, as does the question of how to distinguish its indolent from its aggressive form to reconcile proper management of the disease with age-related...
9.
Baryla I, Kosla K, Bednarek A
J Mol Med (Berl)
. 2022 Oct;
100(12):1691-1702.
PMID: 36271927
WW domain-containing oxidoreductase (WWOX) spans the common fragile site FRA16D. There is evidence that translocations and deletions affecting WWOX accompanied by loss of expression are frequent in many cancers and...
10.
Kolat D, Kaluzinska Z, Bednarek A, Pluciennik E
Cells
. 2022 May;
11(9).
PMID: 35563688
Following the invention of high-throughput sequencing, cancer research focused on investigating disease-related alterations, often inadvertently omitting tumor heterogeneity. This research was intended to limit the impact of heterogeneity on conclusions...